FindDrugs.org

RemedyMeds Review

Brand-level review · Last reviewed Sep 14, 2026

6.03/10

Operator-trust score

The brand-level factors every category shares — legitimacy, clinical oversight, transparency, privacy, policy, support — not price or per-treatment value.

Lowest costClinician accessCash-payInsurance-billed

Our verdict

RemedyMeds is a New Jersey cash-pay telehealth company offering compounded and branded GLP-1 medication on a month-to-month subscription with no membership fee. Its operator-trust score is 6.03 — the brand-level factors every category shares, not price or per-treatment value. Its strengths are access and service record: clinician approval in about 48 hours, two-to-three day shipping, and high recent consumer sentiment that its growth has not eroded. Its weaknesses are disclosure rather than care — it publishes no price on its own site, does not name its compounding pharmacy, and shows press logos and an award badge with nothing to verify them against.

RemedyMeds plans & reviews by category

Each category is scored separately. Read the full review where one exists — or check current pricing directly.

Weight Loss / GLP-1

5.52/10
Read the Weight Loss / GLP-1 reviewCheck price
  • Semaglutide · injection$299/mo
  • Tirzepatide · injection$399/mo
  • Semaglutide · microdosenot disclosed
  • Other · injectionbranded Ozempic / Zepbound at 'retail pricing'

Prices as of Sep 14, 2026 — verify current on the brand's site.

Key takeaways

  • Clinician approval in about 48 hours with two-to-three day shipping from a US pharmacy.
  • Publishes no medication price on its own site — the landing page states month-to-month, cancel-anytime and HSA/FSA accepted with no figure, and there is no reachable pricing page. Price is disclosed only after intake.
  • Discloses that medications are compounded by US-licensed pharmacies but does not name the pharmacy, disclose its 503A/503B status, publish certificates of analysis, or describe cold-chain handling.
  • Displays Forbes, Yahoo, USA Today and Axios press logos with no sourcing links, and a 'Forbes Best of 2026' badge with nothing to verify it against — observed on its own homepage.
  • An FDA warning letter (MARCS-CMS 716830, 2025-09-09) cites false or misleading marketing of compounded semaglutide and tirzepatide.
  • Growth has not cost it its service record: 7,989 of its 13,216 Trustpilot reviews are from the last twelve months and they hold the 4.6/5 average, so there is no rising-volume, falling-score decline.
  • It advertises a 365-day money-back guarantee and pause-adjust-or-cancel-anytime on its own site; the detailed conditions sit on a linked legal page that was not retrievable, so the guarantee is recorded as advertised and its conditions as unverified.

What is RemedyMeds?

RemedyMeds (remedymeds.com) is a direct-to-consumer telehealth company founded in 2024 and based in Summit, New Jersey. It connects patients with US-licensed clinicians who evaluate a short online health questionnaire and, where appropriate, prescribe GLP-1 therapies. It focuses exclusively on weight management. It discloses that its medications are compounded by US-licensed pharmacies and offers branded alternatives, but does not name the compounding pharmacy or state its 503A/503B status. A prescription-volume figure and a 50-state clinician claim previously shown here are withdrawn: neither appears on remedymeds.com and their only source could not be retrieved.

Is RemedyMeds legit?

Qualified yes. RemedyMeds operates with US-licensed clinicians from a verifiable US address, and the September 2025 FDA warning letter it received was a marketing and labelling action issued across an industry-wide compounder wave rather than a quality or safety finding. The caveats are all disclosure: it does not name its compounding pharmacy or its prescribers, it publishes no price on its own site, and it displays media logos and an award badge with nothing behind them.

  • Licensed & accredited: U.S.-licensed clinicians (a 50-state coverage claim was withdrawn as unverifiable); the Sept-2025 FDA warning letter was a marketing/labeling action issued industry-wide, not a quality/safety finding — FDA warning letter (fda.gov), Sep 2025.
  • Clinician model: U.S.-licensed clinicians review intake and approve prescriptions with unlimited follow-ups and included blood work, though intake is a questionnaire and prescribers are not named — ConsumerHealthDigest, Jul 2026.
  • Medication & pharmacy: Discloses that medications are compounded by U.S.-licensed pharmacies and offers branded alternatives, but does not name the compounding pharmacy or disclose its 503A/503B status — RemedyMeds (remedymeds.com), Jul 2026.
  • Watch-outs: The FDA cited its marketing for implying an approval its compounded products don't have, and the site shows unsourced 'Best of 2025' media claims — FDA warning letter (fda.gov), Sep 2025.

Treatment options

What RemedyMeds actually treats. Pricing lives in the plans table above and in each category review.

  • Weight loss (GLP-1)

    compounded semaglutide and tirzepatide by injection, a semaglutide microdose option, and branded Ozempic or Zepbound

Pros & cons

Pros

  • Cash-pay model with no membership fee (monthly price not verifiable from a retrievable source)
  • Strong, high-volume consumer rating: 4.6/5 across 13,216 Trustpilot reviews (86% five-star, 7,989 in the last 12 months)
  • Cancel-anytime, month-to-month model with automated in-portal cancellation and an advertised 365-day money-back guarantee
  • U.S.-licensed clinicians with fast (~48h approval, 2-3 day shipping) fulfillment; HSA/FSA accepted

Cons

  • Does not name its compounding pharmacy or disclose 503A/503B status, COAs, or cold-chain handling
  • Marketing shows unsourced Forbes/USA Today logos and contradictory 'each #1 Best of 2025' claims
  • Specific BMI/age/contraindication screening criteria and headline prices are not shown until after the intake quiz
  • A minority of reviews report unexpected/unauthorized subscription charges and billing surprises
  • Received a Sept-2025 FDA marketing/labeling warning letter (minor; part of an industry-wide compounder enforcement wave)

Verified user experiences

Recency-weighted summaries from verified reports across RemedyMeds. Individual quotes are anonymized.

  • M Salas, verified Trustpilot reviewer (1 star)
    they will bill your credit card $400 every month whether you refill or not. Patients are not made aware that this is a subscription.

    Verified · Jul 23, 2026

  • Leslie, verified Trustpilot reviewer (5 stars)
    Very easy initial set up, fast turn around from start to 1st dose, refill, and then you're off to the races.

    Verified · Jul 23, 2026

The bottom line

RemedyMeds suits people who want a fast, low-friction route to a GLP-1 prescription with easy in-portal cancellation, and who are willing to learn the price after the intake quiz. Anyone who needs the cost up front, wants to know which pharmacy is compounding, or expects marketing claims they can check should weigh those gaps first.

What changed & why

This brand's own history — every re-review and methodology recompute, logged. Rankings change when the evidence or the rules change, never for payment. See the site-wide methodology ledger for version history.

  1. Sep 18, 2026Initial score6.03

    RemedyMeds' Operator Trust Score first recorded at 6.03 out of 10 — the earliest score in this log.

Review score changes

The timeline above is this brand's Operator Trust Score. Each review below is scored separately, and keeps its own history.

  • Weight Management / GLP-1 review— last changed Sep 14, 2026See changes

Work at RemedyMeds?

If something here is wrong or out of date, send us a correction request. We read every one and decide what changes — it does not edit the review or move a score.

Sources & how we researched this

Completeness was not recorded for this score · 4 sources cited

Brand site

Regulatory

Reviews

What we couldn't verify

  • RemedyMeds does not publicly disclose specific eligibility thresholds (BMI cutoff, age minimum) or the rigor of its thyroid/MEN2 contraindication screening; standard GLP-1 criteria are assumed but unconfirmed (brand opacity → scored low, not excluded).
  • The compounding pharmacy is not named on RemedyMeds' own site; a third-party Boothwyn/Link Pharmacy association was found but is unconfirmed by the brand — removed as a score driver per the primary-source rule and logged here.
  • No certificate of analysis (COA), cold-chain, or lot-testing disclosure was found.
  • LegitScript certification is asserted by third-party review sites but was not independently verified on RemedyMeds' own pages during this research.
  • Data-privacy practices (specifics of health-data sharing, breach history) were not verifiable beyond the existence of published policy documents.
  • Named prescribing clinicians and the specifics of ongoing lab-monitoring protocols are not disclosed.
  • Consumer sentiment is inflated to an unknown degree by Trustpilot's 'invites customers to review' status and RemedyMeds' paid Trustpilot subscription; the 4.6/13,216 figure was retrieved via rendered fetch and is used with that caveat.
  • Withdrawn — RemedyMeds' LegitScript certification, 50-state clinician coverage and "over 150,000 prescriptions filled". RemedyMeds' LegitScript certification, 50-state clinician coverage and "over 150,000 prescriptions filled" are WITHDRAWN as stated facts — the source returned HTTP 403 (retrieval-failed, not disproved) and none of the three appears on remedymeds.com. The separately-cited 300,000+ member figure remains, labelled brand-reported, which is the correct treatment for a company claim.
  • Withdrawn — RemedyMeds guarantee as previously stated — "lose at least 10% of your body weight in 4 months or get your money back" —. The RemedyMeds guarantee as previously stated — "lose at least 10% of your body weight in 4 months or get your money back" — is WITHDRAWN because it CONTRADICTS the brand's own site, which advertises a "365-Day Money-Back Guarantee" with "Terms apply on Weight Loss Warranty" and does not state a 10% or 4-month condition (remedymeds.com, fetched 2026-08-10). The warranty terms page was not retrieved, so the actual conditions are unverified in either version.
  • Withdrawn — RemedyMeds pricing ($299/mo semaglutide, $399/mo tirzepatide, flat across dose increases). RemedyMeds pricing ($299/mo semaglutide, $399/mo tirzepatide, flat across dose increases) is WITHDRAWN: it rested on a third-party review page, remedymeds.com publishes no price on its landing page, and /pricing returns HTTP 404 (both fetched 2026-08-10).
  • policy-clarity-fairness: re-encoded as a RETRIEVAL GAP (excluded, re-normalized out of the score) rather than brand opacity. RemedyMeds DOES disclose a policy — a "365-Day Money-Back Guarantee" and "Pause, adjust, or cancel anytime" on its own homepage. What we could not retrieve is the linked warranty terms page. That is a retrieval gap against a disclosure the brand visibly makes, so it cannot score as opacity.
  • The Trustpilot rating shown on this page (4.6/5 across 13,216 reviews, 86% five-star) is NOT withdrawn — but we cannot re-verify it. trustpilot.com is refused on terms: its Terms of Use ban access "through use of automated technologies such as AI agents or screen scrapers", so we have no route to the figure we are permitted to use. It is published here as retrieved on 2026-07-24 and treated as unverifiable from that date forward. The same applies to the two verified-reviewer quotes in the user-experiences section. Separately and recorded rather than resolved: the 2026-07-24 retrieval stamp is shared with provenance records on other brands in this corpus, at least one of which describes a retrieval method that did not exist on that date. That is a question about our own records, not about RemedyMeds, and it is open. (2026-08-25)
Last reviewed Sep 14, 2026View the ledger